Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Structure Therapeutics Inc (GPCR)

Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Structure Therapeutics Inc 601 GATEWAY BLVD. SUITE 900 SOUTH SAN FRANCISCO CA 94080 USA

www.structuretx.com P: 650-457-1978

Description:

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.

Key Statistics

Overview:

Market Capitalization, $K 1,830,835
Enterprise Value, $K 1,701,045
Shares Outstanding, K 46,598
Annual Sales, $ 0 K
Annual Net Income, $ -89,620 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,500 K
EBIT, $ -102,780 K
EBITDA, $ -108,460 K
% of Institutional Shareholders 91.78%
Float, K 46,598
% Float 100.00%
Short Volume Ratio 0.20

Growth:

1-Year Return 62.02%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 03/08/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -0.83
EPS Growth vs. Prev Qtr 19.05%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GPCR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.69%
Return-on-Assets % -30.50%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 4.03
Book Value/Share 9.76
Interest Coverage -1.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar